MADISON, Wis. – Sep 20, 2022 – Invenra Inc., a company developing next generation therapeutic antibodies, announced today that Chief Scientific Officer Daniel Pereira, Ph.D., will present preclinical data supporting... read more →
- Invenra builds out management team to advance immuno-oncology therapeutics pipeline and collaborative discovery efforts - MADISON, Wis. – Jan 5, 2022 – Invenra, Inc., a biotechnology company focused on the... read more →
- Expanded collaboration to include an additional 20 targets for multi-specific antibody, antibody-drug conjugate, and other biologic candidate discovery and development - ALAMEDA, Calif., & MADISON, Wis. – August 16,... read more →